Empiget

  • All Products
  • By Generic
  • By Therapeutic Segment

Empiget

Therapeutic Segment: Anti-Diabetic

Generic Name: Empagliflozin

Indication:

Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus as:

Monotherapy
When diet and exercise alone do not provide adequate glycemic control in patients for whom use of metformin is considered inappropriate due to intolerance.

Add-on combination therapy
In combination with other glucose–lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycemic control.

Available as:

Tablets
  • 10MG
  • 25MG